AUXILIUM PHARMACEUTICALS (NASDAQ: AUXL)





$30.97 0.14 (0.45%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
37.28
52-Week Low Price
21.85
Avg Volume (3 Mo.)
0.00 M
Market Cap
1.45 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-1.29
Shares
47.15 M
Dividend Rate ($) / (%)
0.00/0.00
64%
36%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -6% - AUXL has underperformed the S&P 500 by 32%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
OSI PHARMACEUTICALS INC (OSIP) $34.18 -  $0.01(0.03%)2.02 B
BIOMARIN PHARMACEUTICALS (BMRN) $19.17 -  $0.00(0.00%)1.96 B
CHATTEM INC (CHTT) $93.50 -  $0.18(0.19%)1.77 B
ONYX PHARMACEUTICALS INC (ONXX) $29.05 -  $0.59(2.07%)1.81 B
ABRAXIS BIOSCIENCE NEW (ABII) $35.22 -  $3.18(8.28%)1.57 B
SALIX PHARMACEUTICALS (SLXP) $26.97 -  $0.13(0.48%)1.35 B
MEDICIS PHARMA CORP CL A (MRX) $22.34 -  $0.08(0.36%)1.33 B
IMMUCOR INC (BLUD) $18.71 -  $0.04(0.21%)1.29 B
MEDIVATION INC (MDVN) $36.47 -  $0.02(0.05%)1.24 B
WEST PHARMACEUTICAL SVCS (WST) $36.13 -  $0.62(1.75%)1.19 B
STOCK ANALYSIS
There are currently no Stock Analysis.
AUXL RELATED HEADLINES
arrow
Auxilium's New Hand Drug Jives With Investors
FDA approval for the company's tissue disase treatment sends shares soaring.

Forbes.com 2/3/2010
arrow
Auxilium Gets The Go-Ahead On New Drug
FDA approval for the company's tissue disase treatment sends shares soaring.

Forbes.com 2/3/2010
arrow
Pfizer's Kidney Drug Also Slows Pancreatic Cancer
Drug giant seeks regulatory approval for Sutent as a pancreatic cancer treatment.

Forbes.com 1/22/2010
arrow
Nano Takes Aim At Cancer Cells
Cerulean is engineering nanoparticles to release drugs into tumors instead of into the blood stream.

Forbes.com 8/12/2009
arrow
Condor Strategist Swoops in on Auxilium Pharmaceuticals, Inc. (AUXL)
Auxilium Pharmaceuticals, Inc. (AUXL: sentiment, chart, options) was the center of an intricate option play yesterday, as a spread strategist bet on minimal movement from the stock in September...(Read More)

By SchaeffersResearch 7/1/2009
arrow
Pfizer Becomes Auxilium's European Envoy
The pharmaceutical giant acquires European rights to Xiaflex.

Forbes.com 12/19/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1